LON:BVXP Bioventix (BVXP) Share Price, News & Analysis GBX 1,565 +15.00 (+0.97%) As of 07/17/2026 12:34 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Bioventix Stock (LON:BVXP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Bioventix alerts:Sign Up Key Stats Today's Range 1,550▼ 1,60050-Day Range 1,550▼ 1,85052-Week Range 1,300▼ 2,860Volume24,337 shsAverage Volume10,087 shsMarket Capitalization£81.77 millionP/E Ratio11.14Dividend Yield9.55%Price TargetN/AConsensus RatingN/A Company Overview Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom. Read More Receive BVXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BVXP Stock News HeadlinesBruce Hiscock Buys 534 Shares of Bioventix (LON:BVXP) StockJune 25, 2026 | insidertrades.comDown 43% with a 9% dividend yield – should I buy this stock?June 7, 2026 | uk.finance.yahoo.comCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.July 19 at 1:00 AM | Paradigm Press (Ad)Peter Harrison Spends UK£39k On Bioventix StockApril 12, 2026 | finance.yahoo.comAre Bioventix PLC's (LON:BVXP) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?February 9, 2026 | finance.yahoo.comDown 43%, should I unlock this 8.3% yield for my stocks and shares ISA?January 24, 2026 | msn.comWith 68% ownership of the shares, Bioventix PLC (LON:BVXP) is heavily dominated by institutional ownersJanuary 6, 2026 | finance.yahoo.comPleasing Signs As A Number Of Insiders Buy Bioventix StockDecember 15, 2025 | finance.yahoo.comSee More Headlines BVXP Stock Analysis - Frequently Asked Questions How have BVXP shares performed this year? Bioventix's stock was trading at GBX 1,905 at the beginning of 2026. Since then, BVXP shares have decreased by 17.8% and is now trading at GBX 1,565. How were Bioventix's earnings last quarter? Bioventix PLC (LON:BVXP) announced its quarterly earnings data on Monday, March, 30th. The biotechnology company reported $69.38 earnings per share (EPS) for the quarter. The biotechnology company had revenue of $6.16 billion for the quarter. Bioventix had a net margin of 59.30% and a trailing twelve-month return on equity of 65.83%. How do I buy shares of Bioventix? Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Bioventix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON). Company Calendar Last Earnings3/30/2026Today7/19/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryCannabis Current SymbolLON:BVXP CIKN/A Webwww.bioventix.com Phone+44-1252-728001FaxN/AEmployees12Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 140.52 Trailing P/E Ratio11.14 Forward P/E Ratio9.41 P/E GrowthN/ANet Income£8.12 million Net Margins59.30% Pretax MarginN/A Return on Equity65.83% Return on Assets54.07% Debt Debt-to-Equity RatioN/A Current Ratio6.12 Quick Ratio5.50 Sales & Book Value Annual Sales£12.54 million Price / Sales6.52 Cash FlowGBX 50.67 per share Price / Cash Flow30.89 Book ValueGBX 229.94 per share Price / Book6.81Miscellaneous Outstanding Shares5,225,000Free FloatN/AMarket Cap£81.77 million OptionableNot Optionable Beta0.55 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (LON:BVXP) was last updated on 7/19/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | SponsoredOil is settling in yuan now - here's what that means for goldSaudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...Golden Portfolio | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
